Chekkera Shammi, MBBS, DPM, MRCPsych, FRCPC
- 4Articles
- 15.7KReads
- 2005–2010Active
- 11Collaborators
- 166Citations
About
Chekkera Shammi, MBBS, DPM, MRCPsych, FRCPC, has published research on the pharmacological management of schizophrenia and schizoaffective disorders, including studies on antipsychotic dosing strategies and clozapine-induced hypersalivation. The author has also investigated the renal effects of lithium dosing regimens. Shammi’s work, published between 2005 and 2010, includes clinical trials on long-acting injectable risperidone and dopamine receptor occupancy.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
